Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Eczacıbaşı İlaç PazarlamaEczacıbaşı İlaç Pazarlama
VS
CiplaCipla
Eczacıbaşı İlaç Pazarlama

Eczacıbaşı İlaç Pazarlama

Levent Mahallesi, Büyükdere Caddesi, Ali Kaya Sk. No: 5, İstanbul, 34394, TR

Last Update: 28/04/2026

View Profile
Between 750 and 799
http://www.eip.com.tr
758/1000Fair

Eczacıbaşı Pharmaceuticals Marketing carries out the marketing, promotion, sales and distribution of imported and contract manufactured pharmaceuticals for mass and niche markets and health-based personal care products. Due to its growing portfolio and target audience, ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:610
Subsidiaries:7
12-month incidents
0
Known data breaches
0
Attack type number
0
Cipla

Cipla

Lower Parel, Ganpatrao Kadam Marg,, Mumbai, Maharashtra, IN, 400013

Last Update: 01/04/2026

View Profile
Between 750 and 799
http://www.cipla.com
782/1000Fair

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:50,326
Subsidiaries:7
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Eczacıbaşı İlaç Pazarlama

Eczacıbaşı İlaç Pazarlama

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Cipla

Cipla

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Eczacıbaşı İlaç Pazarlama in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Cipla in 2026.

Incidents

Incident History - Eczacıbaşı İlaç Pazarlama (X = Date, Y = Severity)

Eczacıbaşı İlaç Pazarlama cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Cipla (X = Date, Y = Severity)

Cipla cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Eczacıbaşı İlaç Pazarlama

Eczacıbaşı İlaç Pazarlama

Incidents
No explicit notable incidents reported.
Cipla

Cipla

Incidents
No explicit notable incidents reported.

FAQ

Between Eczacıbaşı İlaç Pazarlama company and Cipla company, which one has the best AI Cybersecurity Score ?
Between Eczacıbaşı İlaç Pazarlama company and Cipla company, which one has experienced more cyber incidents in the past ?
Between Eczacıbaşı İlaç Pazarlama company and Cipla company, which one has experienced more cyber incidents this year ?
Between Eczacıbaşı İlaç Pazarlama company and Cipla company, which one has experienced at least one ransomware attack ?
Between Eczacıbaşı İlaç Pazarlama company and Cipla company, which one has experienced at least one data breach ?
Between Eczacıbaşı İlaç Pazarlama company and Cipla company, which one has experienced at least one targeted cyberattack ?
Between Eczacıbaşı İlaç Pazarlama company and Cipla company, which one has experienced at least one vulnerability ?
Between Eczacıbaşı İlaç Pazarlama company and Cipla company, which one holds the most compliance certifications ?
Between Eczacıbaşı İlaç Pazarlama company and Cipla company, which one holds the fewest compliance certifications ?
Between Eczacıbaşı İlaç Pazarlama company and Cipla company, which one has the most subsidiaries ?
Between Eczacıbaşı İlaç Pazarlama company and Cipla company, which one has the largest number of employees ?
Between Eczacıbaşı İlaç Pazarlama and Cipla, which company holds both SOC 2 Type 1 certifications ?
Between Eczacıbaşı İlaç Pazarlama and Cipla, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Eczacıbaşı İlaç Pazarlama or Cipla ?
Which company is PCI DSS compliant - Eczacıbaşı İlaç Pazarlama or Cipla ?
Between Eczacıbaşı İlaç Pazarlama and Cipla, which company complies with HIPAA regulations for healthcare data ?
Between Eczacıbaşı İlaç Pazarlama and Cipla, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-58523
SUMMARY

Improper access control in Microsoft Edge for Android allows an unauthorized attacker to bypass a security feature over a network.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-14617
SUMMARY

A security vulnerability has been detected in NousResearch hermes-agent up to 2026.4.30. Affected is the function GatewayStreamConsumer._filter_and_accumulate of the file gateway/stream_consumer.py of the component Streaming Reasoning Tag Filter. The manipulation leads to improper handling of case sensitivity. The attack may be initiated remotely. The attack's complexity is rated as high. The exploitability is told to be difficult. The exploit has been disclosed publicly and may be used. The project decided to not implement a dedicated fix: "[T]he analysis and the fix are both sound. It just lands below the bar for the maintenance cost of a duplicated scrub path."

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 3.1)
CVSS2
Base Score: 2.1
Complexity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
CVSS3
Base Score: 3.1
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 1.3
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
1.6
CVE-2026-58597
SUMMARY

Insufficient ui warning of dangerous operations in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-58524
SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 5.4)
CVSS3
Base Score: 5.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N
IMPACT SCORE
2.5
EXPLOITABILITY
2.8
CVE-2026-58522
SUMMARY

Relative path traversal in Microsoft Edge for Android allows an unauthorized attacker to disclose information locally.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 6.8)
CVSS3
Base Score: 6.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N
IMPACT SCORE
4.2
EXPLOITABILITY
2.5